Are typhoid carriers among patients with gallstones at increased risk for carcinoma of the gallbladder?
Chronic typhoid carrier state was the most important risk factor among patients with CaGB and gallstones.
Bevacizumab has significant antitumor activity not only as a single agent or in combination with cisplatin but may also prolong survival when used as maintenance therapy after a complete response to cisplatin-based chemotherapy.